Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 948-021-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Suitable data is available to assess the acute toxicity of the target substance. In an acute oral and in an acute dermal toxicity study no mortality occurred after treatment with 5000 mg/kg bw. Thus, based on the results, the acute oral and dermal LD50 can be considered to be greater than 5000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1972-11-01
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- no
- Remarks:
- study conducted before the implementation of GLP
- Test type:
- standard acute method
- Limit test:
- yes
- Specific details on test material used for the study:
- - Sample marking: RIFM 72-174
- Name: Jasmine Absolute - Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- n.a.
- Route of administration:
- oral: unspecified
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- n.a.
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 10
- Control animals:
- no
- Details on study design:
- n.a.
- Statistics:
- n.a.
- Preliminary study:
- n.a.
- Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- 2 out of 10 rats died overnight on Day 1 of the study.
- Clinical signs:
- other: Slow respiration and lethargy was observed
- Gross pathology:
- n.a.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In conclusion, the oral LD50 in rats after treatment with the test item is considered to be greater than 5000 mg/kg bw.
- Executive summary:
In an acute oral toxicity study conducted similar to OECD 401, ten rats were given a single oral dose of the test item Jasmine absolute at a dose of 5000 mg/kg bw. The animals were observed for a total of 14 days. Two animals died within one day after the treatment. In addition, slow respiration and lethargy were observed as clinical signs of toxicity. In conclusion, the oral LD50 in rats after treatment with the test item is greater than 5000 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- Equivalent to guideline study
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1972-11-01
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- no
- Remarks:
- study conducted before the implementation of GLP
- Test type:
- standard acute method
- Limit test:
- yes
- Specific details on test material used for the study:
- - Sample marking: RIFM 72-174
- Name: Jasmine Absolute - Species:
- rabbit
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- n.a.
- Type of coverage:
- not specified
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- n.a.
- Duration of exposure:
- 14 days
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 6 rabbits
- Control animals:
- no
- Details on study design:
- n.a.
- Statistics:
- n.a.
- Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality observed
- Clinical signs:
- other: No treatment related changes observed
- Gross pathology:
- n.a.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In conclusion, the dermal LD50 in rabbits after treatment with the test item is considered to be greater than 5000 mg/kg bw.
- Executive summary:
In an acute dermal toxicity study conducted similar to OECD 402, six rabbits were given dermally a single dose of the test item Jasmin absolute of 5000 mg/kg bw. The animals were observed for a total of 14 days. No mortality occurred during the observation period and no adverse signs of toxicity were recorded. In conclusion, the dermal LD50 in rats after treatment with the test item is greater than 5000 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
Suitable data is available to assess the acute toxicity of the target substance. In an acute oral toxicity ten rats received a single dose of 5000 mg/kg bw. No mortality occurred during the 14 -day observation period. In an acute dermal toxicity study, six rabbits received dermally a single dose of 5000 mg/kg bw. No mortality occurred during the 14-day observation period. Thus, based on the results, the acute oral and dermal LD50 can be considered to be greater than 5000 mg/kg bw.
Justification for classification or non-classification
Based on the available data, no classification is warranted for acute toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.